Epub 2018 Dec 25
A 0.5 mL syringe (50 unit capacity) with half-unit markings gives you significantly better resolution for small draws
Table of Contents: What is the difference between Semaglutide GLP-1, Ozempic, Wegovy, and Mounjaro
Thyroid 26:13431421 Kahaly GJ, Bartalena L, Hegedus L et al (2018) 2018 European Thyroid Association Guideline for the management of Graves hyperthyroidism

Ozempic (semaglutide) is a GLP-1 receptor agonist administered subcutaneously for type 2 diabetes management Lumps commonly form due to injection technique errors including inadequate site rotation, injecting too rapidly, or removing the needle too soon after injection Normal lumps are firm, mobile, mildly tender, and gradually reduce in size without warmth, spreading redness, or systemic symptoms Seek medical attention for progressive enlargement, increasing pain, signs of infection (warmth, discharge, fever), or difficulty breathing Prevention requires proper technique including systematic site rotation (23 cm from previous sites), keeping the needle in place for at least 6 seconds post-injection, and never reusing needles Lipohypertrophy (persistent rubbery lumps from repeated injections in the same area) impairs medication absorption and requires strict site avoidance Table of Contents Why Lumps Form After Ozempic Injections Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist administered subcutaneously for the management of type 2 diabetes mellitus
